← Back to Search

Web Technology for Opioid Addiction

N/A
Waitlist Available
Led By Lisa Marsch, PhD
Research Sponsored by National Development and Research Institutes, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults (>/= 18 years)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will test whether an interactive, computer-based system can help opioid-dependent patients in office-based buprenorphine treatment.

Who is the study for?
This trial is for adults over 18 years old who are dependent on opioids and currently in their first month of buprenorphine maintenance treatment at an office-based setting. It's not open to those who are using buprenorphine as part of a tapering-off process.Check my eligibility
What is being tested?
The study is testing the effectiveness and cost-efficiency of a computer-based educational tool designed to support patients undergoing treatment for opioid addiction with buprenorphine, which is a medication used to treat opioid dependence.See study design
What are the potential side effects?
While this trial focuses on web technology rather than medication, typical side effects from buprenorphine can include nausea, headaches, drowsiness, constipation, or withdrawal-like symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
opiate use
Secondary outcome measures
HIV risk behavior
feedback on intervention
opiate craving
+3 more

Find a Location

Who is running the clinical trial?

National Development and Research Institutes, Inc.Lead Sponsor
37 Previous Clinical Trials
12,856 Total Patients Enrolled
Lisa Marsch, PhDPrincipal InvestigatorNational Development and Research Institutes, Inc.
2 Previous Clinical Trials
136 Total Patients Enrolled

Media Library

Buprenorphine Clinical Trial Eligibility Overview. Trial Name: NCT00182598 — N/A
Opioid Addiction Research Study Groups:
Opioid Addiction Clinical Trial 2023: Buprenorphine Highlights & Side Effects. Trial Name: NCT00182598 — N/A
Buprenorphine 2023 Treatment Timeline for Medical Study. Trial Name: NCT00182598 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible to still join this experiment?

"The trial in question, which was initially posted on December 1st 2004 and last edited 8/11/2008 is not accepting candidate applications at present. Despite this, 291 distinct clinical trials are presently seeking patient volunteers."

Answered by AI
~4 spots leftby Mar 2025